Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Antiviral Research|June 8, 2025
High-throughput screening for identification of influenza a inhibitors using a cell-based immunofluorescence assayYohanka Martinez-Gzegozewska, Lynn Rasmussen, N Miranda Nebane, et al.
Molecular Therapy. Oncology|April 6, 2026
Identification of small molecules that enhance aminoglycoside-mediated suppression of CFTR and NF1 nonsense mutationsJoshua Sammons, Jianguo Chen, Kari Thrasher, et al.
American Journal of Respiratory and Critical Care Medicine|April 23, 2016
Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense MutationsVenkateshwar Mutyam, Ming Du, Xiaojiao Xue, et al.
Biorxiv : the Preprint Server for Biology|August 26, 2020
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2Catherine Z Chen, Paul Shinn, Zina Itkin, et al.
International Journal of Molecular Sciences|March 11, 2023
Triamterene Functions as an Effective Nonsense Suppression Agent for MPS I-H (Hurler Syndrome)Amna Siddiqui, Halil Dundar, Jyoti Sharma, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
The SARS-CoV-2 cytopathic effect is blocked with autophagy modulatorsKirill Gorshkov, Catherine Z Chen, Robert Bostwick, et al.
ACS Infectious Diseases|July 2, 2019
Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis VirusTheresa H Nguyen, Nicole N Haese, Nikhil Madadi, et al.
Journal of Medicinal Chemistry|May 12, 2025
Discovery of a Chiral 2,4-Substituted Pyrrolo[2,3-d]pyrimidine as a Potent, Selective, and Orally Bioavailable LRRK2 InhibitorOmar Moukha-Chafiq, Tuyana Malankhanova, Jacob Valiyaveettil, et al.
Frontiers in Pharmacology|March 12, 2021
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2Catherine Z Chen, Paul Shinn, Zina Itkin, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 19, 2024
Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitabilityJonathan R Roth, Travis Rush, Samantha J Thompson, et al.
Pageof 4